+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Lyme Disease Market and Competitive Landscape - 2020

  • ID: 5023442
  • Report
  • April 2020
  • Region: Europe
  • Fore Pharma
1 of 2
The research report Europe Lyme Disease Market and Competitive Landscape - 2020, provides comprehensive insights into the Lyme Disease pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Lyme Disease market size and drug sales. It also provides insights into Lyme Disease epidemiology and late stage pipeline.

This research covers the following: Lyme Disease treatment options, Lyme Disease late stage clinical trials pipeline, Lyme Disease prevalence by countries, Lyme Disease market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:
  • Countries: Germany, France, Italy, Spain, UK, Europe
  • Lyme Disease pipeline: Find out drugs in clinical trials for the treatment of Lyme Disease by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Lyme Disease epidemiology: Find out the number of patients diagnosed (prevalence) with Lyme Disease by countries
  • Lyme Disease drugs: Identify key drugs marketed and prescribed for Lyme Disease in the US, including trade name, molecule name, and company
  • Lyme Disease drugs sales: Find out the sales value for Lyme Disease drugs by countries
  • Lyme Disease market valuations: Find out the market size for Lyme Disease drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Lyme Disease drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Lyme Disease drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Lyme Disease market
  • Develop in-depth knowledge of competition and markets
  • Analyze Lyme Disease drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Lyme Disease market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
Note: Product cover images may vary from those shown
2 of 2
1. Lyme Disease Treatment Options

2. Lyme Disease Pipeline Insights
2.1. Lyme Disease Phase 3 Clinical Trials
2.2. Lyme Disease Phase 2 Clinical Trials
2.3. Lyme Disease Phase 1 Clinical Trials

3. Lyme Disease Epidemiology Analysis by Countries

4. Germany Lyme Disease Market Insights
4.1. Marketed Drugs for Lyme Disease in Germany
4.2. Germany Lyme Disease Market Size & Forecast
4.3. Germany Lyme Disease Drugs Sales Forecast
4.4. Germany Lyme Disease Market Share Analysis

5. France Lyme Disease Market Insights
5.1. Marketed Drugs for Lyme Disease in France
5.2. France Lyme Disease Market Size & Forecast
5.3. France Lyme Disease Product Sales Forecast
5.4. France Lyme Disease Market Share Analysis

6. Italy Lyme Disease Market Insights
6.1. Marketed Drugs for Lyme Disease in Italy
6.2. Italy Lyme Disease Market Size & Forecast
6.3. Italy Lyme Disease Product Sales Forecast
6.4. Italy Lyme Disease Market Share Analysis

7. Spain Lyme Disease Market Insights
7.1. Marketed Drugs for Lyme Disease in Spain
7.2. Spain Lyme Disease Market Size & Forecast
7.3. Spain Lyme Disease Product Sales Forecast
7.4. Spain Lyme Disease Market Share Analysis

8. UK Lyme Disease Market Insights
8.1. Marketed Drugs for Lyme Disease in UK
8.2. UK Lyme Disease Market Size & Forecast
8.3. UK Lyme Disease Product Sales Forecast
8.4. UK Lyme Disease Market Share Analysis

9. Europe Lyme Disease Market Insights
9.1. Europe Lyme Disease Market Size & Forecast
9.2. Europe Lyme Disease Product Sales Forecast
9.3. Europe Lyme Disease Market Share Analysis

10. Research Methodology

List of Tables
Table 1: Lyme Disease Phase 3 Clinical Trials, Global, 2020
Table 2: Lyme Disease Phase 2 Clinical Trials, Global, 2020
Table 3: Lyme Disease Phase 1 Clinical Trials, Global, 2020
Table 4: Lyme Disease Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Lyme Disease in Germany, 2019
Table 6: Germany Lyme Disease Market Size & Forecast ($mn), 2016 - 2024
Table 7: Germany Lyme Disease Product Sales ($mn), 2016 - 2024
Table 8: Germany Lyme Disease Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Lyme Disease in France, 2019
Table 10: France Lyme Disease Market Size & Forecast ($mn), 2016 - 2024
Table 11: France Lyme Disease Product Sales ($mn), 2016 - 2024
Table 12: France Lyme Disease Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Lyme Disease in Italy, 2019
Table 14: Italy Lyme Disease Market Size & Forecast ($mn), 2016 - 2024
Table 15: Italy Lyme Disease Product Sales ($mn), 2016 - 2024
Table 16: Italy Lyme Disease Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Lyme Disease in Spain, 2019
Table 18: Spain Lyme Disease Market Size & Forecast ($mn), 2016 - 2024
Table 19: Spain Lyme Disease Product Sales ($mn), 2016 - 2024
Table 20: Spain Lyme Disease Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Lyme Disease in UK, 2019
Table 22: UK Lyme Disease Market Size & Forecast ($mn), 2016 - 2024
Table 23: UK Lyme Disease Product Sales ($mn), 2016 - 2024
Table 24: UK Lyme Disease Market Events and Trends, 2016 - 2024
Table 25: Europe Lyme Disease Market Size & Forecast ($mn), 2016 - 2024
Table 26: Europe Lyme Disease Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Lyme Disease Pipeline by Phase (%), Global, 2020
Figure 2: Lyme Disease Prevalence by Countries, 2016 - 2024
Figure 3: Germany Lyme Disease Market Size ($mn), 2016 - 2024
Figure 4: Germany Lyme Disease Product Sales ($mn), 2016 - 2024
Figure 5: Germany Lyme Disease Market Share by Drugs (%), 2019
Figure 6: Germany Lyme Disease Market - Future Market Share (%), 2024
Figure 7: France Lyme Disease Market Size ($mn), 2016 - 2024
Figure 8: France Lyme Disease Product Sales ($mn), 2016 - 2024
Figure 9: France Lyme Disease Market Share by Drugs (%), 2019
Figure 10: France Lyme Disease Market - Future Market Share (%), 2024
Figure 11: Italy Lyme Disease Market Size ($mn), 2016 - 2024
Figure 12: Italy Lyme Disease Product Sales ($mn), 2016 - 2024
Figure 13: Italy Lyme Disease Market Share by Drugs (%), 2019
Figure 14: Italy Lyme Disease Market - Future Market Share (%), 2024
Figure 15: Spain Lyme Disease Market Size ($mn), 2016 - 2024
Figure 16: Spain Lyme Disease Product Sales ($mn), 2016 - 2024
Figure 17: Spain Lyme Disease Market Share by Drugs (%), 2019
Figure 18: Spain Lyme Disease Market - Future Market Share (%), 2024
Figure 19: UK Lyme Disease Market Size ($mn), 2016 - 2024
Figure 20: UK Lyme Disease Product Sales ($mn), 2016 - 2024
Figure 21: UK Lyme Disease Market Share by Drugs (%), 2019
Figure 22: UK Lyme Disease Market - Future Market Share (%), 2024
Figure 23: Europe Lyme Disease Market Size ($mn), 2016 - 2024
Figure 24: Europe Lyme Disease Product Sales ($mn), 2016 - 2024
Figure 25: Europe Lyme Disease Market Share by Drugs (%), 2019
Figure 26: Europe Lyme Disease Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll